[HTML][HTML] Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis
Minocycline has anti-inflammatory, antioxidant, and anti-apoptotic properties that explain the
renewed interest in its use as an adjunctive treatment for psychiatric and neurological …
renewed interest in its use as an adjunctive treatment for psychiatric and neurological …
Minocycline in neurodegenerative and psychiatric diseases: an update
D Romero‐Miguel, N Lamanna‐Rama… - European Journal of …, 2021 - Wiley Online Library
Background and purpose Minocycline is a broad‐spectrum antibiotic, effective as a chronic
treatment for recurrent bacterial infections. Beyond its antibiotic action, minocycline also has …
treatment for recurrent bacterial infections. Beyond its antibiotic action, minocycline also has …
Minocycline: therapeutic potential in psychiatry
OM Dean, J Data-Franco, F Giorlando, M Berk - CNS drugs, 2012 - Springer
Pharmacological interventions to treat psychiatric illness have previously focused on
modifying dysfunctional neurotransmitter systems to improve symptoms. However, imperfect …
modifying dysfunctional neurotransmitter systems to improve symptoms. However, imperfect …
Adjunctive minocycline for major mental disorders: a systematic review
W Zheng, XM Zhu, QE Zhang… - Journal of …, 2019 - journals.sagepub.com
Objectives: This meta-analysis of randomized controlled trials (RCTs) examined the efficacy
and safety of minocycline for three major mental disorders: schizophrenia, bipolar disorder …
and safety of minocycline for three major mental disorders: schizophrenia, bipolar disorder …
Clinical potential of minocycline for schizophrenia
T Miyaoka - CNS & Neurological Disorders-Drug Targets …, 2008 - ingentaconnect.com
Minocycline, an antibiotic of the tetracycline family, has been shown to display
neurorestorative or neuroprotective properties in various models of neurodegenerative …
neurorestorative or neuroprotective properties in various models of neurodegenerative …
Efficacy and tolerability of minocycline for depression: a systematic review and meta-analysis of clinical trials
JD Rosenblat, RS McIntyre - Journal of affective disorders, 2018 - Elsevier
Background Minocycline has been identified as a potential novel treatment for depression.
The objective of the current review is to determine the overall antidepressant efficacy and …
The objective of the current review is to determine the overall antidepressant efficacy and …
Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia
M Solmi, N Veronese, N Thapa, S Facchini… - CNS …, 2017 - cambridge.org
ObjectiveOur aim was to perform an updated systematic review and meta-analysis on the
efficacy and safety of adjunctive minocycline as a treatment of schizophrenia. MethodsWe …
efficacy and safety of adjunctive minocycline as a treatment of schizophrenia. MethodsWe …
Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta‐analysis of randomized controlled trials
K Oya, T Kishi, N Iwata - Human Psychopharmacology: Clinical …, 2014 - Wiley Online Library
Objective This study aimed to perform a comprehensive meta‐analysis of minocycline
augmentation therapy in patients with schizophrenia receiving antipsychotic agents …
augmentation therapy in patients with schizophrenia receiving antipsychotic agents …
A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.
Y Levkovitz, S Mendlovich, S Riwkes… - Journal of Clinical …, 2010 - psychiatrist.com
Background: Current antipsychotics have only a limited effect on 2 core aspects of
schizophrenia: negative symptoms and cognitive deficits. Minocycline is a second …
schizophrenia: negative symptoms and cognitive deficits. Minocycline is a second …
[HTML][HTML] Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial
Background Depression is one of the leading causes of disability worldwide. A high
proportion of patients do not respond to standard drug treatments. Recent evidence has …
proportion of patients do not respond to standard drug treatments. Recent evidence has …